Bob Kay, Jeff Barber and Gary Brock join the Board of Directors, offering extensive experience and expertise in the areas of business management and growth, healthcare and technology
MORRISVILLE, N.C., August 26, 2021 – Myocardial Solutions (“MSI”) announced the addition of three new board members: Bob Kay, Jeff Barber and Gary Brock. Jeff replaces Bill Burke as Chair of the Audit Committee. Bill was an outstanding Director but was forced to resign as a result of new time commitments after becoming Chairman of the Board for a second public company.
Bob Kay is currently the Managing Member and the CEO of Excelleration Partners (EP), which focuses on helping early-stage growth companies accelerate their growth while also excelling at what they do. Additionally, Bob serves as part of the Board of MSC Income Fund, Inc., a Houston, Texas private equity investment fund. Bob has served as Chief Executive Officer and/or Chief Operating Officer of multiple start-ups, growth phase, and turnaround operating company situations. He brings over 40 years of broad-based banking, investments, private equity intermediary, and private business management experience to help MSI excel as startup as the company grows commercially.
Jeff Barber is a Managing Director with Fennebresque & Co., a Charlotte, NC-based investment banking firm where he focuses on technology and healthcare. Jeff also serves on the board of trustees and as chair of the audit committee of Blue Cross Blue Shield of North Carolina – the state’s largest health insurer – as well as on the board of directors and as past chair at Echo Health Ventures. Jeff previously served as a partner at PricewaterhouseCoopers, in charge of the technology practice in the Carolinas. He was also on the board of directors for PRA Health Sciences, Ply Gem, SciQuest, Inc., and LipoScience, Inc., solidifying his expertise to help MSI navigate the business of healthcare as a medical technology.
Gary Brock has over 40 years of progressive healthcare executive leadership and governance experience. Brock has served Baylor Scott & White Health (BSWH) for more than 35 years in numerous leadership positions including President and Chief Operating Officer of the legacy Baylor Healthcare system. Under Brock’s leadership, he created one of the largest and top-performing Accountable Care Organizations (ACO) in Texas and in the nation, focusing on patient centered care with an emphasis on assuring adherence to evidence based/best practice and quality standards of care. He served as a member of the Board of Trustees of the Texas Hospital Association, Austin, Texas for seven years and was elected chairman of the board in 2014. Gary’s experience in progressive healthcare and operations will help to propel MSI forward as MyoStrain transitions to becoming a new standard in cardiac care.
“These new board members are highly experienced healthcare managers and directors and will offer unique perspectives on an emerging growth company like Myocardial Solutions.” said John Funkhouser, CEO. “We are excited to have them on the Board.”
Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 500 publications in clinical research and development, MSI’s proprietary technology, MyoStrain®, is a 10-minute, non-invasive MRI heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe.
To learn more about MyoStrain, visit myocardialsolutions.com or connect with us on LinkedIn and Twitter @myocardialsoln.